A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers
Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether lansoprazole, once daily (QD), compared to
gefarnate, twice daily (BID), is effective in preventing the recurrence of gastric and
duodenal ulcers in patients receiving long term treatment with low dosage aspirin.